{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:00:11Z","timestamp":1788184811282,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.hoc.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T16:12:20Z","timestamp":1680711140000},"page":"499-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nonsurgical Therapy for Early-Stage Lung Cancer"],"prefix":"10.1016","volume":"37","author":[{"given":"Megan E.","family":"Daly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Beagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2023.02.002_bib1","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.21037\/jtd-20-2367","article-title":"Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size <\/= 5 cm: a propensity score matching analysis","volume":"12","author":"Dong","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.hoc.2023.02.002_bib2","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.ejca.2014.09.006","article-title":"Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis","volume":"50","author":"Matsuo","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hoc.2023.02.002_bib3","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JCO.2009.25.0928","article-title":"Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer","volume":"28","author":"Grills","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G","article-title":"Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience","volume":"82","author":"Uematsu","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2023.02.002_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/PL00002379","article-title":"Stereotactic radiotherapy of targets in the lung and liver","volume":"177","author":"Wulf","year":"2001","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hoc.2023.02.002_bib9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","article-title":"Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer","volume":"124","author":"Timmerman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2023.02.002_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0003-4975(02)04681-7","article-title":"Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial","volume":"75","author":"Whyte","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hoc.2023.02.002_bib11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2023.02.002_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ijrobp.2008.11.019","article-title":"Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer","volume":"73","author":"Xiao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"Space - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib16","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.cllc.2018.09.004","article-title":"Five-year long-term outcomes of stereotactic body radiation therapy for operable versus medically inoperable stage I non-small-cell lung cancer: analysis by operability, fractionation regimen, tumor size, and tumor location","volume":"20","author":"Schonewolf","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.hoc.2023.02.002_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.adro.2019.01.002","article-title":"Long-term clinical outcomes and safety profile of SBRT for centrally located NSCLC","volume":"4","author":"Arnett","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2019.08.019","article-title":"One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial","volume":"105","author":"Singh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib21","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib22","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2018.11.036","article-title":"Chest wall toxicity after stereotactic body radiation therapy: a pooled analysis of 57 studies","volume":"103","author":"Ma","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib25","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ijrobp.2011.03.053","article-title":"Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer","volume":"82","author":"Mutter","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","article-title":"Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites","volume":"93","author":"Forquer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.hoc.2023.02.002_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2023.02.002_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2023.02.002_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib31","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib32","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2023.02.002_bib33","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2023.02.002_bib34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2023.02.002_bib35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.21037\/tlcr-20-1231","article-title":"Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases","volume":"10","author":"Chan","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.hoc.2023.02.002_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0929-8266(01)00126-4","article-title":"Radiofrequency tumor ablation: principles and techniques","volume":"13","author":"Goldberg","year":"2001","journal-title":"Eur J Ultrasound"},{"key":"10.1016\/j.hoc.2023.02.002_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1067\/j.cpradiol.2007.10.001","article-title":"Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?","volume":"38","author":"Brace","year":"2009","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.hoc.2023.02.002_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/01.RVI.0000092666.72261.6B","article-title":"Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors","volume":"14","author":"Lu","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2023.02.002_bib39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4254\/wjh.v7.i8.1054","article-title":"Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma","volume":"7","author":"Poulou","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hoc.2023.02.002_bib40","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.jvir.2009.12.403","article-title":"Cryoablation: mechanism of action and devices","volume":"21","author":"Erinjeri","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2023.02.002_bib41","first-page":"1031","article-title":"Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB\/IV non-small cell lung cancer","volume":"19","author":"Das","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.hoc.2023.02.002_bib42","doi-asserted-by":"crossref","first-page":"521691","DOI":"10.1155\/2014\/521691","article-title":"Cryoablation of early-stage primary lung cancer","volume":"2014","author":"Inoue","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.hoc.2023.02.002_bib43","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.7150\/thno.67530","article-title":"Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation","volume":"12","author":"Kwak","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.hoc.2023.02.002_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2214\/AJR.21.25872","article-title":"Active versus passive thaw after percutaneous cryoablation of pulmonary tumors: effect on incidence, grade, and onset of hemoptysis","volume":"217","author":"Wrobel","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hoc.2023.02.002_bib45","doi-asserted-by":"crossref","first-page":"e27086","DOI":"10.1371\/journal.pone.0027086","article-title":"Percutaneous cryoablation of pulmonary metastases from colorectal cancer","volume":"6","author":"Yamauchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hoc.2023.02.002_bib46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1183\/09031936.00188014","article-title":"Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer","volume":"45","author":"Ambrogi","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hoc.2023.02.002_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtcvs.2008.08.034","article-title":"Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer","volume":"137","author":"Lanuti","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hoc.2023.02.002_bib48","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/cncr.29507","article-title":"Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial","volume":"121","author":"Dupuy","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2023.02.002_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13019-018-0773-y","article-title":"Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial","volume":"13","author":"Palussiere","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.hoc.2023.02.002_bib50","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/JTO.0b013e31822d538d","article-title":"Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study","volume":"6","author":"Ambrogi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.hoc.2023.02.002_bib51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/02656736.2018.1434901","article-title":"Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis","volume":"34","author":"Yao","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.hoc.2023.02.002_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25259\/JCIS_224_2020","article-title":"Computerized tomography-guided microwave ablation of patients with stage I non-small cell lung cancers: a single-institution retrospective study","volume":"11","author":"Nance","year":"2021","journal-title":"J Clin Imaging Sci"},{"key":"10.1016\/j.hoc.2023.02.002_bib53","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jvir.2022.04.019","article-title":"Microwave ablation versus stereotactic body radiotherapy for stage I non-small cell lung cancer: a cost-effectiveness analysis","volume":"33","author":"Wu","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2023.02.002_bib54","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jvir.2014.12.006","article-title":"Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients","volume":"26","author":"Moore","year":"2015","journal-title":"J Vasc Interv Radiol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882300014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882300014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:18:37Z","timestamp":1760185117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985882300014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S088985882300014X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2023.02.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsurgical Therapy for Early-Stage Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}